background: Myofibroblastic, peritubular cells in the walls of seminiferous tubules produce low levels of the extracellular matrix (ECM) protein decorin (DCN), which has the ability to interfere with growth factor (GF) signaling. In men with impaired spermatogenesis, fibrotic remodeling of these walls and accumulation of tryptase-positive mast cells (MCs) occur.
Introduction
Flat, spindle-like peritubular cells and the extracellular matrix (ECM) build a wall, which separates the germinal epithelium of the seminiferous tubules from the interstitial compartment of the testis. The testicular peritubular cells (TPC) of this wall are myofibroblastic cells (Cigorraga et al., 1994) , which form several layers in humans (HTPC) and are thought to be important for the transport of sperm and testicular fluid (Rossi et al., 2002; Romano et al., 2005; Zhang et al., 2006; Welsh et al., 2009; Schell et al., 2010) . In addition, peritubular cells secrete a number of paracrine factors, participating in the control of testicular functions (Schell et al., 2008 (Schell et al., , 2010 Spinnler et al., 2010) .
Testicular peritubular cells are assumed to also secrete components of the ECM of the peritubular wall (Maekawa et al., 1996) . Surprisingly, the full spectrum of these proteins and the exact composition of the ECM of the peritubular wall in man have not been defined but type IV collagen, heparin sulfate proteoglycan, fibronectin and laminin have been observed in ECM (Santoro et al., 2000; Dobashi et al., 2003) . Of these, collagen type IV is a product of HTPC, and so is the proteoglycan decorin (DCN; Ungefroren et al., 1995) . Ungefroren et al. (1995) located DCN gene expression to cells of the peritubular wall and interstitial fibroblastic cells of normal adult human testes. Interestingly, in other species, testicular DCN has not been examined or is absent in developing mouse gonads (Miqueloto and Zorn, 2007) . DCN belongs to the family of secreted small leucine-rich proteoglycans. Originally the name was given because it can 'decorate' collagen fibrils, thereby regulating collagen fibrillogenesis-a key mechanism of ECM assembly and homeostasis (Reed and Iozzo, 2002; Zhu et al., 2005; Schaefer and Iozzo, 2008) .
In addition, two other actions of DCN have been recognized, linking DCN to fundamental biological functions, including cell migration, adhesion and proliferation (Nili et al., 2003; Ferdous et al., 2010) . First, DCN binds a variety of soluble and insoluble ligands, thus regulating their activity and availability. This is well documented, for instance, for transforming growth factor-beta (TGF-b; Macri et al., 2007) and platelet-derived GF (PDGF; Nili et al., 2003) . Second, DCN itself can act as a non-selective ligand for several growth factor receptors (GFRs), including epidermal GFR (EGFR; Schaefer and Iozzo, 2008) , insulin-like GFR 1 (IGF1R; Schaefer and Iozzo, 2008) , vascular endothelial GFR (VEGFR; Iacob et al., 2008) and hepatocyte GFR (HGFR; Goldoni et al., 2009 ). It appears that DCN may cause initial activation of the respective signaling pathway, followed by its inactivation as shown, for example, for EGFR (Zhu et al., 2005) .
Could DCN interfere with GF/GFR signaling also in the human testis and in the peritubular wall? The answer to this question could be of potential interest for the understanding of testicular development Puglianiello et al., 2004; Ricci et al., 2004; Nurmio et al., 2007; Basciani et al., 2010) , for the understanding of the adult human testis and for human male infertility (Nakazumi et al., 1996) . In human male infertility, striking alterations of the cellular components of the peritubular wall and of the ECM (Davidoff et al., 1990; Haider et al., 1999; Gulkesen et al., 2002) are evident; however, surprisingly little is known about this remodeling process. We recently reported hypertrophy and loss of contractility markers in peritubular cells of men with impaired spermatogenesis, indicating a switch of the cellular phenotype of peritubular cells from contractile cells to synthesizing cell types (Schell et al., 2010) . Whether this switch may also affect the secretion of DCN by peritubular cells (Ungefroren et al., 1995) is not known but in a number of other human fibrotic remodeling processes (e.g. pulmonary and nephrogenic systemic fibrosis; van Straaten et al., 1999; Fadic et al., 2006; Gambichler et al., 2009) , increases in DCN production were reported.
What induces the fibrotic remodeling, called a hallmark of human male infertility (De Kretser and Baker, 1996) , remains unknown but mast cells (MCs) and macrophages may be involved via their direct and indirect products. This assumption is based on observations in vivo and on results of cell culture experiments. It is established now that many more immune cells are present in the peritubular wall in testes with fibrotic changes (Meineke et al., 2000; Frungieri et al., 2002a,b; Spiess et al., 2007; Matzkin et al., 2010) . The secreted products of MCs and macrophages, namely tryptase and tumor necrosis factor alpha (TNF-a), and also a prostaglandin metabolite, have been shown to regulate the cellular phenotype and secretory behavior of human fibroblasts and/or of HTPCs (Frungieri et al., 2002a; Albrecht et al., 2005; Schell et al., 2008) .
The successful isolation of HTPCs, and recently also of the corresponding cells from testes of men with existing fibrotic changes (HTPC-Fs; Spinnler et al., 2010) , has opened a door to the examination of the role of this unexplored human testicular cell type. We made use of these unique models for human testicular cells in the present study. HTPCs and HTPC-Fs are comparable in most aspects and both produce DCN and, as we found, both are targets for DCN, which acts as a ligand for GF receptors. Yet, HTPCs and HTPC-Fs differ with respect to the levels of DCN production and its regulation, and thus mirror the in vivo situation of the human testis in health and disease.
Materials and Methods
Isolation of HTPC/HTPC-Fs, cell culture and human testicular samples Isolation of HTPC/-Fs was performed as described previously (Albrecht et al., 2006; Schell et al., 2008 Schell et al., , 2010 . HTPCs originate from patients displaying normal spermatogenesis, whereas HTPC-Fs were isolated from men suffering from impaired spermatogenesis and testicular fibrosis. All participants granted written informed consent. The local ethics committee approved the study.
All cells, passages 3 -12, were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS; both from PAA GmbH, Cö lbe, Germany), unless indicated otherwise. After initial screening with several concentrations in order to determine optimal response, treatments with 100 ng/ml human recombinant (rhSkin b) tryptase (Promega GmbH, Mannheim, Germany) and 10 mM protease activated receptor (PAR-2) agonist peptide SLIGKV (NeoMPS, Strasbourg, France) were performed for 72 h, as detailed later. Solvent (H 2 O) for these substances was included as control. Cells were cultured in the presence of 10 mg/ml DCN (human recombinant, Immundiagnostik AG, Bensheim, Germany or bovine articular cartilage, Sigma Aldrich, Deisenhofen, Germany), 50 ng/ml EGF (human recombinant, New England Biolabs, Frankfurt, Germany) or/and 5 ng/ml PDGF-BB (the BB homodimeric form, human recombinant, Sigma) for 24 h, as described later. These concentrations were chosen based on the results of dose-response tests (not shown). PDGF-BB was dissolved in 4 mM HCl containing 0.1% bovine serum albumin (BSA; stock; PAA GmbH) and was used at a 1:1000 dilution (4 mM). Hence the stock solution without PDGF was added to the media as a control.
For immunohistochemical studies, human testicular samples from men with normal or pathologically altered spermatogenesis were used, as described previously (Meineke et al., 2000; Frungieri et al., 2002a,b; Albrecht et al., 2006; Schell et al., 2010) . We focused on samples of mixed atrophy (MA) patients, which can show unaltered peritubular walls as well as focally altered areas in the same sections.
Immunohistochemistry and immunocytochemistry
Immunohistochemistry and immunofluorescence methods were performed, as previously described (Albrecht et al., 2006; Schell et al., 2008 Schell et al., , 2010 . A monoclonal goat anti-human DCN antibody (1:100; R&D Systems, Wiesbaden-Nordenstadt, Germany) was used to stain deparaffinized 5-mm-thick sections. Cells from at least three different patients (HTPC-Fs and HTPCs) were used for each immunofluorescence experiment. Monoclonal mouse antibodies against smooth muscle actin (SMA; 1:2000; clone 1A4, Sigma), CD90 (1:100; clone AS02; Dianova GmbH, Hamburg; Germany) and collagen type I (1:200; clone I-8H5; Acris Antibodies GmbH; Hiddenhausen, Germany) were employed. Incubation with normal non-immune serum instead of the specific antibody, or omission of the primary antibody, served as controls.
Isolation of RNA, RT -PCR, semi-quantitative RT-PCR and quantitative (q)RT-PCR
HTPCs and HTPC-Fs from at least three different donors were grown to sub-confluence and incubated with/without tryptase (100 ng/ml) or SLIGKV (10 mM) in DMEM medium containing 10% FCS for 72 h. Subsequently cells were washed twice with DMEM without FCS and suspended in RLT-buffer (QIAGEN GmbH, Hilden, Germany) containing 1% b-mercaptoethanol.
QIAGEN RNeasy minikit was used for RNA-isolation, followed by reverse transcription using random hexamer primers. Four hundred nanograms of total RNA were used for further semi-quantitative RT-PCR experiments (Frungieri et al., 2002a; Schell et al., 2010) . For information about primers, annealing temperatures and product sizes, see Schell et al. (2010) and Table I . PCR products were visualized by ethidium bromide staining in agarose gels. As a positive control, commercially available human testes cDNA (Clontech, Palo Alto, CA, USA) was used. Identities of all PCR products were verified by sequencing (Schell et al., 2010) .
Synthesis of cDNAs for qRT -PCR was performed by using the DyNAmo two-step SYBR Green qRT -PCR kit (Finnzymes Oy, Espoo, Finland) and the Engine Opticon system (MJ Research, Inc., Waltham, MA, USA) for continuous fluorescent detection was used. Samples were analyzed in triplicate. The expression levels were determined in proportion to the ribosomal protein L19 (RPL19) housekeeping gene (Li et al., 2006; Strauss et al., 2009) . Cells from at least three patients in each group were examined.
Western blotting
HTPC/-Fs grown on 60-mm dishes (Nunc GmbH & Co. KG, Wiesbaden, Germany) were incubated in the presence or absence of tryptase (100 ng/ ml) or SLIGKV (10 mM) in DMEM medium containing 10% FCS for 72 h. We performed immunoblots, as described in previous studies (Frungieri et al., 2002a) , using the same monoclonal DCN (1:1,000, R&D Systems) and SMA (1:500; Sigma) antibodies as for immunohistochemistry. The use of a beta-actin antibody (1:5000, Sigma) allowed corrections for small differences in loading. Western blot bands were detected with chemiluminescent reagents (SuperSignal w West Femto Maximum Sensitivity Substrate, Pierce, Thermo Scientific, Rockford, IL, USA) and analyzed densitometrically with ImageJ Software (National Institutes of Health, Bethesda, MD, USA; version 1.40g) and the results normalized to those obtained for b-actin. We repeated the experiments with cells from at least three different patients of each group, HTPCs and HTPC-Fs, and also used four freshly obtained biopsy samples.
Enzyme-linked immunosorbent assay
DCN was detected in conditioned media by using a commercial immunoassay (R&D Systems) according to the manufacturer's protocol (100 ml of the conditioned media diluted 1:1000). The medium supernatants (total 2 ml per 60-mm dish) of the same tryptase/SLIGKV-treated and untreated control cells that were used in the western blot experiments, were examined. The results were expressed as secreted DCN per mg total cellular protein.
Phosphorylation assays: screening using proteome profiler and western blotting A total of 10 6 cells (HTPCs) were seeded on a 60-mm dish and treated for 5 min with 10 mg/ml DCN, i.e. a concentration, which induced robust increases in intracellular Ca 2+ . For controls, phosphate-buffered saline (PBS) was added to the culture medium. Cellular protein was extracted and used in an antibody-based array for human phospho-receptor tyrosin kinases (RTKs), according to the manufacturer's protocol (Proteome Profiler; R&D Systems; IGEPAL, Sigma). In brief, cell lysates were prepared with a Nonidet P-40 lysis buffer, added to nitrocellulose membranes on which antibodies were spotted, and incubated overnight at 48C. After washing steps, membranes were incubated with an anti-phospho-tyrosine-horse-radish peroxidase detection antibody for 2 h at room temperature on a rocking platform shaker. The wash step was repeated. Chemiluminiscent reagent (Pierce w ECL Western Blotting Substrate, Thermo Scientific) was added and images were captured. Results were evaluated with ImageJ Software. The experiment was repeated twice.
The ability of DCN, EGF and PDGF-BB to phosphorylate EGFR and PDGFR-b was further studied by western blotting. HTPC/-Fs were incubated with 10 mg/ml DCN, 50 ng/ml EGF or 5 ng/ml PDGF-BB for 10 min in DMEM without FCS. To exclude non-specific protein effects, cells from each patient were treated with 10 mg/ml BSA (pH ¼ 7.8; PAA GmbH). Other control cells were incubated in the presence of PBS. Immunoblotting was performed using 0.5 mg/ml rabbit anti-phospho-PDGFR-b (1:100) or 0.4 mg/ml anti-phospho-EGFR solution (1:250; antibodies were identical to the ones used in the Proteome Profiler assay). For control purposes, monoclonal rabbit anti-human EGFR antibody (1:100; Thermo Fisher Scientific Inc., Fremont, CA, USA) and polyclonal rabbit anti-human PDGFR antiserum (1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were also used.
Measurements of intracellular Ca 21
Intracellular Ca 2+ levels were measured as described in previous studies (Fohr et al., 1993; Albrecht et al., 2006) . In brief, cells were grown on cover slips for 24 h in DMEM supplemented with 10% FCS, loaded with 5 mM fluo-4, acetoxy-methylester (fluo-4AM; Molecular Probes, Eugene, OR, USA) for 30 min at 378C and 5% CO 2 . After washing the cells with FCS-free DMEM, the cover slip was transferred into a recording chamber mounted on a TCS SP2 confocal microscope (Leica Microsystems, Bensheim, Germany). Fluorescence was monitored at 500 -540 nm (l ex ¼ 488 nm) every 2 s and the intensity was quantified over single cells. To assess whether HTPC/-Fs may possess functional PAR-2, changes of intracellular Ca 2+ levels were recorded on-line while applying 100 ng/ml tryptase or 10 mM agonist peptide SLIGKV to cells (of at least three different patients for each group). In pilot experiments, 10 mg/ml bovine articular cartilage DCN, as well as human recombinant DCN, were compared. No difference in the ability of the DCN preparation to mobilize intracellular Ca 2+ was observed. Subsequently, unless indicated otherwise, bovine DCN was generally used but for each experiment human recombinant DCN was tested as well to control for any possible difference in actions. Experiments evaluating the actions of different concentrations of EGF (50 ng/ml, 250 ng/ml and 1 mg/ml) and PDGF-BB (5 and 10 ng/ml) were also conducted. In additional experiments, cells (n ¼ 3 HTPCs and n ¼ 2 HTPC-Fs) were pretreated with 10 mg/ml DCN for 24 h before measuring changes in Ca 2+ levels with acute stimulation by EGF, PDGF or DCN. In addition, the response to histamine (100 mM) was tested (see Albrecht et al., 2006) . Measurements of Ca 2+ levels after adding 10 ml/ml BSA (pH ¼ 7.8) were performed to exclude non-specific protein effects.
Cell viability and proliferation
Viability of cells was assessed using the CellTiter-Glow Luminescent Cell Viability Assay (Promega GmbH, Mannheim, Germany). Cells were seeded in quadruplicate in 24-well tissue culture plates and incubated for 24 h with/without DCN (10 mg/ml). The kit reagents were added directly to the cells, and luminescence of the luciferase reaction was measured in a FLUOstar Optima (BMG Labtech GmbH, Offenburg, Germany) reader. Cells from five men with normal testis and five patients with fertility problems were used. To evaluate mitotic figures of cultured HTPC/-Fs, DAPI (4 ′ ,6 ′ -diamidino-2 ′ -phenylindole; 1.5 mg/ml; Vectashield mounting medium, Vector laboratories, Burlingame, CA, USA) was used, as described (Kunz et al., 2006) . For this study, HTPCs and HTPC-Fs from 3 to 12 different men were used. Different time points (6, 18 and 24 h) were studied. Only at 24 h was a significant increase of proliferative events in treatment groups over untreated controls observed. At 20× magnification, all nuclei (.200/slide) were counted and the percentages of metaphase, anaphase and telophase figures were determined.
Laser capture microdissection
Sections (5 mm) of human-paraffin-embedded biopsies were mounted onto thin polyethylene naphthalene membrane, as previously described (Frungieri et al., 2002a, b) . The sections were deparaffinized, lightly stained with hamalaune/eosin and subjected to laser capture microdissection (LMD; P.A.L.M. GmbH Mikrolaser Technologie, Bernried, Germany). This allowed the isolation of peritubular walls from surrounding tissue. The samples were kept frozen (2808C) until RT-PCR was performed. RNA was extracted using the RNeasy FFPE kit (QIAGEN) and subjected to RT-PCR using oligo-dT primers. In order to ensure that the sections contained suitable RNA for this procedure, a whole deparaffinized consecutive section was also scraped from the slide and processed as described. For information on primers and PCR conditions (see Table I ). Amplified products were sequenced.
Data analysis and statistics
Results obtained were analyzed using PRISM 4.0 (GraphPad Software, Inc., San Diego, CA, USA). t-Test or one-way analysis of variance (ANOVA) tests were performed, as indicated. Differences between the groups were evaluated with the appropriate post hoc tests (e.g. NewmanKeuls Multiple Comparison) and all data are expressed as mean + SEM. Statistical significance was set at P , 0.05.
Results
Extracellular and intracellular sites of DCN in the peritubular wall in normal testes and testes of infertile patients: Accumulation of DCN in the ECM of MA patients DCN can be readily detected in human testes by immunohistochemistry, both in normal testes, as expected ( Fig. 1A and B) , and in testes of men with impaired spermatogenesis and interstitial and tubular fibrosis ( Fig. 1C-E ; n ¼ 3 normal, n ¼ 8 MA). In either group, DCN staining in the ECM of the interstitial and the peritubular compartment, as well as staining of peritubular cells, was evident. In the cases of impaired spermatogenesis and interstitial and tubular fibrosis, however, the fibrotically remodeled tubular wall stood out and the immunohistochemical signals indicated that DCN is deposited in the thickened layers of the ECM. As seen in sections of the MA patients, the accumulation of DCN in the thickened ECM of completely fibrotically remodeled tubules contrasted with only weakly stained ECM areas of the tubular walls in the unaffected neighbouring normal tubules (Fig. 1D) . As the cytoplasm of peritubular cells also stained (Fig. 1E) , these cells are the likely to synthesize DCN. Interstitial ECM deposits were also evident and the staining pattern obtained suggests that interstitial fibroblasts are the likely source of DCN (Fig. 1D) . Controls with non-immune serum and omission of primary antibody were negative (Fig. 1B) .
Expression and identity of DCN were confirmed by RT-PCR (Fig. 1F ) and sequencing (data not shown) in normal human testes and by western blotting using four biopsy samples of men with normal spermatogenesis (Fig. 1F) .
HPTCs express DCN in vitro: Higher basal DCN levels in HTPC-Fs than in HTPCs
HTPCs and HTPC-Fs are derived from patients with normal or impaired spermatogenesis, respectively, and have been characterized in part previously (Schell et al., 2010; Spinnler et al., 2010) . Both lack receptors for LH or FSH, but express receptors for TNF-a and PAR-2. HTPCs and HTPC-Fs produce similar amounts of glial-cell-line-derived neurotrophic factor (GDNF). This production was not affected by tryptase (Spinnler et al., 2010) . We confirmed by RT-PCR and immunocytochemistry the expression of fibroblast markers (collagen type IV, CD90) and smooth muscle cell markers, namely SMA, myosin heavy chain (MYH11) and calponin (Schell et al., 2010 ; data not shown and Supplemental data, Fig. S1A ). Furthermore, western blotting revealed that HTPCs and HTPC-Fs contain similar amounts of SMA (Supplemental data, Fig. S1B ). With respect to DCN, we found that HTPCs and HTPC-Fs [n ¼ 3-7 patients/ group; RT-PCR/sequencing, western blotting and enzyme-linked immunosorbent assay (ELISA) measurements] produce DCN, which is secreted into the culture medium (Fig. 2) . However, significant quantitative differences became apparent. Higher DCN mRNA levels in HTPC-Fs when compared with HTPCs were shown by qRT-PCR ( Fig. 2A ) and higher cellular DCN levels were confirmed by western blotting (Fig. 2B and C) . ELISA data revealed that, within 24 h, HTPC-Fs released significantly greater quantities of DCN into the medium than HTPCs (Fig. 2D) . Constitutive secretion occurred and the levels further increased up to 72 h. Thus, higher expression and secretion of DCN in HTPC-Fs are reminiscent of higher expression levels and DCN deposits in ECM in the testes of infertile men, as indicated by immunohistochemistry.
Tryptase stimulates DCN production and secretion via PAR-2 in HTPC-Fs but not in HTPCs
We confirmed that HTPCs and HTPC-Fs possess functional receptors for the MC product tryptase, PAR-2, by showing immediate consequences, namely elevations of intracellular Ca 2+ . Using this approach we found that the percentage of HTPCs and HTPC-Fs (n ¼ 3/group) responding to 100 ng/ml tryptase and 10 mM SLIGKV (a selective PAR-2 peptide agonist) by increasing Ca 2+ did not differ (Supplemental data, Fig. S2 ). However, HTPC-Fs but not HTPCs responded to tryptase and SLIGKV by increasing DCN production and secretion. When different concentrations of these substances were tested, 100 ng/ml tryptase and 10 mM SLIGKV proved to be effective stimulators of DCN secretion after 72 h (Supplemental data, Fig. S3 ). These concentrations were therefore used for subsequent studies, which showed that tryptase and SLIGKV increased not only the amounts of secreted DCN but also DCN mRNA and cellular protein levels (72 h) in HTPC-Fs but not in HTPCs (Fig. 3 ).
GFRs are expressed by HTPC/HTPC-Fs: Acute actions of DCN include increases in intracellular Ca 21 levels and phosphorylation of GFRs 
-test).
To account for possible small differences in applied protein amounts, DCN levels were normalized to b-actin levels and given in a.u. Cells of three different patients/group were used. (C) A representative western blot result for DCN and b-actin expression in HTPCs and HTPC-Fs. (D) An ELISA was used to quantify DCN protein released from HTPC/HTPC-Fs into the culture media (mean + SEM; 24 and 72 h). When amounts secreted over a period of 24 h were compared, HTPC-Fs were found to secrete significantly more DCN than HTPCs (P , 0.05, t-test). No statistically significant difference became obvious when the amounts secreted during 72 h were compared. Different letters above the columns indicate significant differences. All results were normalized to total cellular protein and given in a.u. Numbers within columns show the number of patients.
GFRs (Fig. 4A and B) . Human recombinant and calf DCN were equally effective. When BSA (10 mg/ml) was used, intracellular Ca 2+ was not altered (Fig. 4C) .
To obtain a profile of GFRs, known from other systems to be potential partners of DCN, RT-PCR screening followed by sequencing (not shown) was used. In HTPCs and HTPC-Fs we found evidence for receptors of the EGFR family, including EGFR, ErbB2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2), ErbB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3) and ErbB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4), PDGF receptors (PDGFR-a and PDGFR-b), IGF1R, HGFR and VEGR (Fig. 5A) .
Next we examined whether exogenous DCN may be able to activate these RTKs or interfere with receptor signaling. In a dot blot screening, DCN (10 mg/ml), when added to HTPCs for 5 min, caused phosphorylation of EGFR (n ¼ 2). Phosphorylation was also found in case of HGFR, but not in cases of VEGFR or IGF1R (data not shown). Subsequent western blot experiments revealed that DCN (10 mg/ml) added to HTPCs and HTPC-Fs for 10 min, phosphorylates EGFR, but not PDGFR-b (Fig. 5B) . Phosphorylation of EGFR and PDGFR occurred, as expected, in response to 50 ng/ml EGF or 5 ng/ml PDGF-BB respectively. Cells from three patients with functional spermatogenesis and from two patients with impaired spermatogenesis and testicular fibrosis were used. Importantly, addition of BSA did not result in signals and therefore a non-specific protein effect can be excluded (Fig. 5B) .
Furthermore, EGF (50 ng/ml) and PDGF (5 ng/ml), similar to DCN alone, increased intracellular Ca 2+ in HTPCs and HTPC-Fs (Fig. 5C ).
When cells were pre-treated with 10 mg/ml DCN for 24 h, intracellular Ca 2+ levels did not change when challenged with EGF or PDGF-BB but cells still responded to a challenge by histamine (data not shown).
Chronic action of DCN includes inhibition of EGF-and PDGF-mediated proliferation in HTPC/HTPC-Fs
The role of GFs and their receptors in the human peritubular compartment, in general, is not well known (Saito et al., 2001; Mariani et al., 2002; Puglianiello et al., 2004; Romano et al., 2006) . To define the actions of EGF/EGFR and PDGF/PDGFR in HTPC/-Fs, we next examined the ability of recombinant human EGF and PDGF-BB to stimulate cell proliferation. PDGF-BB and EGF significantly increased proliferation of HTPC/-Fs (i.e. percentage of mitotic figures; Fig. 6A ), an effect observed at 24 h but not at the earlier time points of 6 or 18 h after treatment. Importantly, DCN did not affect proliferation at any of these time points (data for 6 an 18 h not shown) but the stimulatory actions of recombinant human EGF and PDGF-BB were significantly inhibited by DCN. When cellular ATP levels were examined, similar significant changes and inhibitory actions of DCN on EGF and PDGF were found (data not shown). This implies that DCN, if present for 24 h, blocks the consequences of EGFR and PDGFR activation but does not act on its own. Finally, in order to determine whether EGFRs and PDGFRs are expressed in the human peritubular wall of MA patients, this compartment was excised by LMD and subjected to RT-PCR. Both EGFR and Figure 3 The major mast cell product, tryptase, via PAR-2 stimulates DCN production and secretion in HTPC-Fs. (A) DCN mRNA levels at 72 h in HTPCs and HTPC-Fs after exposure to 100 ng/ml tryptase or 10 mM PAR-2 agonist peptide SLIGKV (quantitative RT -PCR). DCN mRNA levels in stimulated HTPC-Fs, but not HTPCs, are significantly higher than in untreated control cells (P , 0.05; mean + SEM; ANOVA followed by Newman -Keuls test). Results (arbitrary units: a.u.) were normalized to the housekeeping gene RPL19. Numbers within columns show the number of patients. (B) DCN protein levels in HTPCs and HTPC-Fs at 72 h after treatment with tryptase (100 ng/ml) and PAR-2 agonist peptide SLIGKV (10 mM; western blot experiments). Tryptase/ SLIGKV significantly increased DCN protein levels in HTPC-Fs (P , 0.05; ANOVA followed by Newman-Keuls test). Results were normalized to b-actin protein levels (a.u.). Data shown are mean + SEM values of blots performed with 3 -5 patients/group. (C) Example of secreted amounts of DCN (ELISA). Data shown are the duplicate measurements obtained with cells from one patient/group. Note that a significant increase in secreted DCN levels became evident only in HTPC-F samples treated with tryptase or SLIGKV when n ¼ 4/group were examined (not shown; P , 0.05; ANOVA followed by Newman-Keuls test). Values were normalized to total protein.
Decorin and human male infertility PDGFR-a/-b mRNAs were identified in the human peritubular walls with normal and fibrotic morphology (Fig. 6B ).
Discussion
Years ago Ungefroren et al. (1995) identified DCN as a product of cells of the testicular peritubular wall and of interstitial fibroblasts in healthy men. Testes of infertile men were not examined at that time. Our study now, by using immunohistochemistry and biopsies from normal and infertile men, confirm the cellular sites of DCN production. In addition, we found a striking accumulation of DCN in the ECM in the testes of men with in-or subfertility in the fibrotically remodeled tubular walls. This is in accordance with increased DCN production in several human fibrotic conditions (Van Straaten et al., 1999; Fadic et al., 2006; Gambichler et al., 2009) .
Peritubular cells are the producers of DCN and increased production by these cells, possibly along with a reduced ability to degrade DCN, is presumably responsible for the deposits we observed. That peritubular cells from infertile men do have a greater ability to produce and secrete DCN in a constitutive manner was shown when isolated HTPC-Fs, stemming from men with fibrotic changes, were tested and compared with HTPCs, i.e. cells derived from men with normal peritubular walls. Hence, we are confident that the primary cells used here mirror the in vivo situation.
The second distinct difference between HTPCs and HTPC-Fs was the ability of MC tryptase and a peptide agonist at the tryptase receptor, PAR-2, to increase DCN mRNA and protein levels in HTPC-Fs but not in HTPCs. However, both HTPCs and HTPC-Fs possess functional PAR-2 (Spinnler et al., 2010) and responded acutely in a manner similar to tryptase and to an agonist peptide with elevations of intracellular Ca 2+ . Neither HTPCs nor HTPC-Fs responded to tryptase by altered production of GDNF, as we found in a previous study (Spinnler et al., 2010) . Thus the increased 'sensitivity' to tryptase in HTPC-Fs is a distinct signature of these cells derived from patients with existing fertility problems. The reason for this increased 'sensitivity' to tryptase in HTPC-Fs may be related to the altered microenvironment in the fibrotic peritubular wall, which includes factors derived from MCs and/or macrophages (Meineke et al., 2000; Frungieri et al., 2002b) . Such a link is supported by the observed loss of smooth muscle cell markers in peritubular cells (Schell et al., 2010) . The fact that cultured HTPCs and HTPC-Fs respond in different ways and thus appear to mimic the in vivo situation indicates that these cells are excellent models for the study of properties of peritubular cells from testes of normal and infertile patients, respectively.
Regulation of DCN via PAR-2 activation, as observed in HTPC-Fs has, to our knowledge, not been reported but the activation of a related receptor, protease activated receptor-1 (PAR-1) by thrombin resulted in increased DCN expression (Ivey and Little, 2008) . In addition, interleukin-1 (IL-1) and IL-4 can induce DCN transcription, while TNF-a and TGF-b are potent inhibitors of DCN expression (Pulkkinen et al., 1992; Mauviel et al., 1995; Wegrowski et al., 1995) . In the context of the human peritubular wall in infertility, TNF-a could be released from MCs or macrophages, as they both express this cytokine and both are found in significantly higher numbers in states of infertility at this location (Frungieri et al., 2002a; Schell et al., 2008) .
DCN in the human testes may have roles in the assembly and/or protection of the ECM (Reed and Iozzo, 2002; Schaefer and Iozzo, 2008; Seidler and Dreier, 2008 ) may serve as a reservoir for GFs and may influence GF/GFR-interaction and the consequent signaling cascade. As it is not possible to test any of these assumed functions of DCN in the human testis in health and disease in vivo, studies in primary cells, namely HTPC/-Fs, appear appropriate. Previous studies pinpointed EGF/EGFR, PDGF/PDGFR, VEGF/VEGFR, HGF/ HGFR and IGF/IGF1R as ligand/receptors systems that can be affected by DCN (Iacob et al., 2008; Schaefer and Iozzo, 2008; Goldoni et al., 2009) . In the present study, we identified all of these receptors in HTPC/-Fs. Decorin and human male infertility EGFRs are reported in peritubular cells of the adult human testis (Nakazumi et al., 1996) . Our LMD/RT-PCR studies confirm this site of expression and also identified PDGFRs, at least in biopsies from MA patients. A previous study employing immunohistochemistry and testes samples from normal, healthy adult men did not report expression of PDGFR-a and PDGFR-b in peritubular regions ). Yet during development, PDGFR-a and PDGFR-b are present and PDGF is considered as an important regulator for peritubular cells Nili et al., 2003; Romano et al., 2005; D'Antoni et al., 2008) . Whether expression of PDGFRs in adult human peritubular cells in vivo may occur again during initiation and progression of sub-or infertility is a question that remains to be fully studied.
EGF and PDGF have important roles in the regulation of smooth muscle cell proliferation and differentiation (1993; Nili et al., 2003; Dreux et al., 2006) . EGFR and PDGFR can form heterodimers and transactivation by one of the respective ligands may occur (Saito et al., 2001 ). This may be of relevance to peritubular cells, which are smooth muscle-like cells (Schell et al., 2010) . The present study provides evidence for functional EGFRs and PDGFRs and shows that DCN interferes with the RTK and/or the ligand. We observed that EGF and PDGF, as well as exogenous DCN, transiently induced elevations of intracellular Ca 2+ levels, which occurred within seconds and lasted only for seconds. This observation suggests activation of receptors, including GFRs, and is in accordance with the view that DCN can bind to GFRs, especially EGFRs, and can activate them acutely (Zhu et al., 2005; Iacob et al., 2008; Schaefer and Iozzo, 2008; Goldoni et al., 2009) . The concentration of DCN required for this action was higher than expected, based on the K D of DCN for EGFR ( 87 nM; Iozzo and Schaefer, 2010) . However, HTPCs and HTPC-Fs constantly secrete DCN, which may thus constantly downregulate EGFRs and/or other GFs/GFRs and hence higher concentrations are required in the experimental setting. In support of this assumption, pretreatment of HTPC/-Fs with exogenous DCN for 24 h abolished the ability of DCN, EGF and PDGF, but not of histamine (Albrecht et al., 2006) , to elevate Ca 2+ levels.
To study the mechanisms of DCN action further, we investigated GFR phosphorylation. As expected (Zhu et al., 2005) , DCN appeared to directly interfere with EGFRs and caused phosphorylation of EGFR in HTPCs and HTPC-Fs, a result that was found in screening experiments and was confirmed by western blot. Under the same experimental conditions, PDGFR-b was not phosphorylated by DCN. This is in line with the ability of DCN to bind this GFR-ligand, rather than to affect phosphorylation of PDGFRs (Nili et al., 2003; Kozma et al., 2009) .
Our screening indicates that HGFR may be another potential receptor for DCN, while VEGR and IGF1R, at least under the experimental conditions used here, may not be affected by DCN. A final conclusion cannot be drawn however, from our study. The binding of DCN occurs with different affinities to different receptors and thus expression patterns of GFRs and the concentrations of available DCN are of importance (Iozzo and Schaefer, 2010) . In order to address these points, additional experiments are required.
We performed experiments to explore the role of DCN with respect to the EGF/EGFR and PDGF/PDGFR systems. We found, as suggested by animal studies Romano et al., 2006) , that both EGF and PDGF evoked a strong proliferative response in HTPC/-Fs. These effects were observed after 24 h but not at 6 h or 18 h. Importantly, the addition of DCN significantly reduced the mitogenic actions of both GFs, a result that clearly shows that DCN is a factor that is able to interfere with GFs, their signaling and actions. When DCN alone was added for longer periods showed that DCN can significantly block EGF/PDGF actions (PDGF at 5 ng/ml; EGF at 50 ng/ml; DCN at 10 mg/ml; means + SEM; results are expressed in percentage; P , 0.05). Different letters above the columns indicate significant differences between the groups (P , 0.05; ANOVA followed by Newman-Keuls test). DAPI staining of nuclei of cells of at least three different patients (HTPC and HTPC-F) was performed (small picture within the panel in the middle; bar: 1 mm). Numbers in columns give numbers of patients. (B) Areas of the peritubular wall were excised by LMD and subjected to RT -PCR (EGFR: nested, PDGFR-a: nested, PDGFR-b: semi-nested). Results indicated the presence of PDGFR-a and -b in human peritubular (PT) walls from MA patients (which contain normal and fibrotic tubules). HTPC and whole testes cDNAs were used as positive control, and DNA was omitted from the control (2). Bar: 40 mm.
(up to 24 h) to cultured HTPC/-Fs, it did not alter cellular viability or cell proliferation, a result in line with studies in human airway smooth muscle cells (D'Antoni et al., 2008) . This lack of action of DCN after 24 h also indicates that an initial activation, as shown by transiently increased Ca 2+ levels or phosphorylation of the EGFR, is followed by a down-regulation of EGR signaling (Csordas et al., 2000; Zhu et al., 2005) . In the case of PDGF, we suggest that DCN bound the GF and thus abolished its proliferative potential. It is worth mentioning that the present investigation revealed DCN staining also in the interstitial compartment of the human testis and that several GFRs have been described in Leydig cells (Gnessi et al., 1995; Basciani et al., 2002) . Thus, the ability of DCN to interfere with GF actions in the human testis may extend to Leydig as well as other cell types.
In summary, the present study provides insights into the roles of DCN as a factor involved in testicular paracrine signaling. Results of our study using cultured human testicular cells from normal and sub/-infertile men support such actions. Furthermore our results indicate that in the testes of men with impaired spermatogenesis, the typical fibrotic changes include increased amounts of the ECM protein DCN, which we suggest consequently may lead to an imbalance in testicular GF signaling via direct actions and/or by serving as a reservoir of GFs. Although we observed increased levels of DCN in HTPC-Fs, we could detect no difference between HTPCs and HTPC-Fs with regard to the Ca 2+ increase, mitotic activity and phosphorylation of EGFRs and PDGFRs. Despite this, we cannot rule out the possibility that increased levels of DCN upset the normal balance of testicular function, including the actions of GFs. In men with impaired spermatogenesis, testicular MCs are increased in number and our study shows that their major product, tryptase, can act as a regulator of DCN production by peritubular cells. Hence, the results also indicate that the functions of testicular MCs may be intrinsically linked to testicular alterations in infertile men. In the search for novel therapeutic interventions in male infertility MCs may be a key cell type to target (Meineke et al., 2000; Frungieri et al., 2002b; Schell et al., 2008 Schell et al., , 2010 .
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